Zhengye Biotechnology Holding Ltd (ZYBT) — 6-K Filings
All 6-K filings from Zhengye Biotechnology Holding Ltd. Browse 6 Foreign Current Report reports with AI-powered summaries and risk analysis.
6-K Filings (6)
- 6-K Filing — Dec 12, 2025
-
Zhengye Biotech Receives NASDAQ Delinquency Notice
— May 23, 2025 Risk: medium
Zhengye Biotechnology Holding Limited received a delinquency notice from NASDAQ on May 20, 2025, for failing to file its Form 20-F for the fiscal year ended Dec -
Zhengye Biotechnology Forms New Company via Capital Contribution
— Apr 3, 2025 Risk: low
On March 28, 2025, Jilin Zhengye Biological Products Co., Ltd., the operating entity of Zhengye Biotechnology Holding Limited, entered into an Agreement for Cap -
Zhengye Biotechnology Appoints Aiden Han as Co-CEO
— Mar 6, 2025 Risk: low
On March 5, 2025, Zhengye Biotechnology Holding Limited appointed Mr. Aiden Han as Co-Chief Executive Officer. This appointment was recommended by the company's -
Zhengye Biotech IPO: Underwriters Exercise Full Over-Allotment Option
— Jan 14, 2025 Risk: low
On January 13, 2025, Kingswood Capital Partners, LLC, acting for the underwriters, fully exercised their over-allotment option for Zhengye Biotechnology Holding -
Zhengye Biotechnology Closes IPO
— Jan 8, 2025 Risk: medium
Zhengye Biotechnology Holding Limited announced the closing of its initial public offering (IPO) on January 8, 2025. The company successfully sold 1,500,000 ord
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX